Stock Analysis

Emami Third Quarter 2025 Earnings: EPS Beats Expectations

NSEI:EMAMILTD
Source: Shutterstock

Emami (NSE:EMAMILTD) Third Quarter 2025 Results

Key Financial Results

  • Revenue: ₹10.5b (up 5.3% from 3Q 2024).
  • Net income: ₹2.79b (up 8.0% from 3Q 2024).
  • Profit margin: 27% (in line with 3Q 2024).
  • EPS: ₹6.39 (up from ₹5.92 in 3Q 2024).
earnings-and-revenue-growth
NSEI:EMAMILTD Earnings and Revenue Growth February 3rd 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Emami EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.6%.

Looking ahead, revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Personal Products industry in India.

Performance of the Indian Personal Products industry.

The company's shares are up 14% from a week ago.

Risk Analysis

Before you take the next step you should know about the 1 warning sign for Emami that we have uncovered.

Valuation is complex, but we're here to simplify it.

Discover if Emami might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:EMAMILTD

Emami

Manufactures and markets personal and healthcare products in India and internationally.

Flawless balance sheet established dividend payer.

Community Narratives

Leading the Game with Growth, Innovation, and Exceptional Returns
Fair Value SEK 300.00|49.486999999999995% undervalued
Investingwilly
Investingwilly
Community Contributor
Why ASML Dominates the Chip Market
Fair Value €864.91|16.442% undervalued
yiannisz
yiannisz
Community Contributor
Global Payments will reach new heights with a 34% upside potential
Fair Value US$142.00|20.528% undervalued
Maxell
Maxell
Community Contributor